ADMA Biologics
ADMA
#4089
Rank
A$4.44 B
Marketcap
A$20.04
Share price
-1.62%
Change (1 day)
-18.48%
Change (1 year)

Earnings for ADMA Biologics (ADMA)

Earnings in 2026 (TTM): A$0.35 Billion

According to ADMA Biologics 's latest financial reports the company's current earnings are A$0.51 Billion. In 2025 the company made an earning of A$0.28 Billion, an increase over its 2024 earnings that were of A$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADMA Biologics from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.35 B25.25%
2025 A$0.28 B35.89%
2024 A$0.20 B-4446.66%
2023 -A$4.83 Million-93.11%
2022 -A$70.03 Million-20.42%
2021 -A$88 Million-8.11%
2020 -A$95.77 Million62.31%
2019 -A$59.01 Million-34.76%
2018 -A$90.45 Million48.79%
2017 -A$60.79 Million134.28%
2016 -A$25.95 Million7.12%
2015 -A$24.23 Million0.3%
2014 -A$24.15 Million7.85%
2013 -A$22.4 Million71.04%
2012 -A$13.1 Million28864%
2011 -A$0.05 Million35.22%
2010 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
A$46.07 M-87.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.34 Billion-191.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$33.44 Million-109.08%๐Ÿ‡บ๐Ÿ‡ธ USA